Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Pain Physicians (US)(?)

Council Members in this Study Group: 511

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.

Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...

Walter Carlini, MD, PhD
Neurologist
Medford Neurological Clinic, Inc.

Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...

Josef Parvizi, MD, Attending Neurologist, Stanford University Medical CenterJosef Parvizi, MD
Attending Neurologist
Stanford University Medical Center

Josef Parvizi, MD, PhD, is an Assistant Professor of Neurological Sciences at Stanford University. Dr. Parvizi has main interest in analyzing the design and results of new clinical trials, of medications or devices, in various fields of neurology. He has clinical expertise in Alzheimer's disease, neuropathic...

Sabry Ayad, MD
Chairman of Anesthesiology and Critical Care
Westgate Medical Anesthesia Group

Sabry Ayad, MD, is a member of Westgate Medical Anesthesia Group, a private practice that provides a full range of anesthesia services for local healthcare facilities in Ohio. Through his employment at Westgate Medical Anesthesia Group, he is the Chairman of Anesthesiology and Critical Care at Fairview...

Jason Campagna, MD,PhD, Director of Clinical Quality and Analytics, Cottage Health SystemJason Campagna, MD,PhD
Director of Clinical Quality and Analytics
Cottage Health System

Jason Campagna, MD, PhD, is an Anesthesiologist at Anesthesia Medical Group of Santa Barbara in California. He is also Director of Center for Clinical Quality and Analytics at Cottage Health System, an Adjunct Professor of neuroscience and serves as the Director of Center for Applied Neurosciences...

Stephen Landy, MD
Director of Neurology
Wesley Headache Clinic

Stephen Landy, MD, is the Director of Neurology at Wesley Headache Clinic and Clinical Professor in Department of Neurology at University of Tennessee. Dr. Landy is certified by the National Board of Medical Examiners, the American Board of Psychiatry and Neurolgy. Also, he is certified by the National...

Ira Kornbluth, MD, Managing Partner, Spine Medicine and Rehabilitation TherapiesIra Kornbluth, MD
Managing Partner
Spine Medicine and Rehabilitation Therapies

Ira Kornbluth, MD, is the Managing Partner at Spine Medicine and Rehabilitation Therapies in Westminster, Maryland. He is board certified in Physical Medicine and Rehabilitation as well as board certified in Pain Management. He was a partner at the Center for Pain Management and DECK Pain Management...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
POISE: don't let it change your practice | 08-06-2008
Author: GLG Expert Contributor

1. 10% of the data was rejected because the data was "fraudulent" - ie: research centers received payment, but there was not actually a patient associated with the data points. 2. No oversight was conducted of the research locations.  A majority of research centers were in various 3rd world countries. ...

Patients will continue to decrease the use of these agents for reasons that I can speculate are largely related to lack of perceived efficacy the fear of the unknown | 07-28-2008
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor

This should not deter the practicing physician to prescribe these agents osteoporosis will reach epidemic proportions and if we can reduce fractures by 50% the savings within the healthcare system will be enormous that's not to say that individuals albeit rare may have a propensity to develop fractures...

The Pleitropic Effects of Volatile Anesthetics: Pain and Inhaled Agents? | 07-02-2008
Analysis of: Why anaesthetics can make the pain worse | www.newscientist.com
Author: Jason Campagna, MD,PhD, Director of Clinical Quality and Analytics, Cottage Health System

There are well over 70 Million general anesthetics performed in the US each year, and the majority of these utilize one of four generally used inhaled anesthetic agents (Sevoflurane, Desflurane, Isoflurane and Halothane). How these drugs act to produce "unconsciousness" is largely unknown, but as the...

Anesthetic factors that modulate postoperative pain | 07-02-2008
Analysis of: Why anaesthetics can make the pain worse | www.newscientist.com
Author: GLG Expert Contributor

1/ Genetic factors. Data indicate that genetic factors modulate the anesthetic requirement to control pain duirng and after surgery 2/ Gender sensitivity to anesthetics 3/ Anesthesia or lack of it  may lead to increase postoperative pain 4/ lack of proper perioperative monitoring of pain 5/ lack...

Novartis and Multiple Sclerosis: A Major Commitment | 06-05-2008
Author: Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.

Extavia, Novartis' brand of  interferon beta 1b, has been approved for the  treatment of multiple sclerosis by the European Union.  With FTY72, Fingolimod, Novartis has the eye on filing NDA by the end of 2009.  While essentially identical to Bayer's Betaferon interferon beta 1b,...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • President
  • Director
  • Partner
  • Medical Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-06T21:45:17.077